Although it seems necessary to further explore the role of FAAH in controlling monocyte/macrophage functions during AD, along with the underlying molecular mechanisms, this study unfolds new opportunities for a FAAH-oriented therapy targeting specific cells of the innate immune system. The gene discussed is FAAH; the disease is Alzheimer disease.